|By PR Newswire||
|September 2, 2014 05:00 AM EDT||
COSTA MESA, Calif., Sept. 2, 2014 /PRNewswire-iReach/ -- WCCT Global, a multi-site contract research organization was just recognized as one of the fastest growing companies in America by INC 5000. Over the past few years, the company has undergone significant growth in four main areas: early phase clinical research, late phase global clinical development, anti-viral and vaccine development, and patient recruitment. Over the past 2 years, WCCT Global has successfully participated in over 150 early and late phase clinical trials. In addition, WCCT Global's Global clinical development department has successfully managed numerous data management and medical writing opportunities which has also played a large role in the growth of the company.
WCCT Global's Chief Operating Officer, Jon Rojas stated, "We are pleased to be recognized for our growth by INC 5000. This achievement can mainly be attributed to our talented and devoted staff, nationwide. With our success in clinical research and the strategic partnerships the company has taken, WCCT Global continues to be the CRO of choice for many of our sponsor partners."
Over the next year, this full service CRO will continue to grow and be a leader in the clinical development industry due to their current service offerings and new innovative service offerings. With the recent acquisition of the H1N1 virus and the completion of construction to their dedicated influenza challenge unit, this makes WCCT Global the only commercial influenza challenge unit in the United States. Other areas of continued growth projected for the next year will be with their patient recruitment division called "In-Site" which offers clients a risk free option to only pay for successfully randomized patients. With all of these capabilities, WCCT Global is poised to be contract research organization that will continue to grow year after year.
More about WCCT Global:
WCCT Global is a multi-site, full service pharmaceutical contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management, patient recruitment services, and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, influenza, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Renal, and Vaccines.
To request more information about WCCT Global's services, CLICK HERE
Media Contact: Matt Miller, WCCT Global, 714.668.1500 ext.2029, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE WCCT Global
Aug. 30, 2015 12:00 PM EDT Reads: 245
Aug. 30, 2015 11:00 AM EDT Reads: 156
Aug. 30, 2015 10:30 AM EDT Reads: 425
Aug. 30, 2015 10:30 AM EDT Reads: 860
Aug. 30, 2015 10:15 AM EDT Reads: 208
Aug. 30, 2015 10:00 AM EDT Reads: 327
Aug. 30, 2015 10:00 AM EDT Reads: 215
Aug. 30, 2015 09:45 AM EDT Reads: 177
Aug. 30, 2015 09:15 AM EDT Reads: 432
Aug. 30, 2015 09:15 AM EDT Reads: 600
Aug. 30, 2015 08:45 AM EDT Reads: 565
Aug. 30, 2015 08:45 AM EDT Reads: 334
WSM International, the pioneer and leader in server migration services, has announced an agreement with WHOA.com, a leader in providing secure public, private and hybrid cloud computing services. Under terms of the agreement, WSM will provide migration services to WHOA.com customers to relocate some or all of their applications, digital assets, and other computing workloads to WHOA.com enterprise-class, secure cloud infrastructure. The migration services include detailed evaluation and planning...
Aug. 30, 2015 08:45 AM EDT Reads: 155
The Internet of Things (IoT) is about the digitization of physical assets including sensors, devices, machines, gateways, and the network. It creates possibilities for significant value creation and new revenue generating business models via data democratization and ubiquitous analytics across IoT networks. The explosion of data in all forms in IoT requires a more robust and broader lens in order to enable smarter timely actions and better outcomes. Business operations become the key driver of I...
Aug. 30, 2015 08:30 AM EDT Reads: 385
Puppet Labs has announced the next major update to its flagship product: Puppet Enterprise 2015.2. This release includes new features providing DevOps teams with clarity, simplicity and additional management capabilities, including an all-new user interface, an interactive graph for visualizing infrastructure code, a new unified agent and broader infrastructure support.
Aug. 30, 2015 07:15 AM EDT Reads: 494